Ji Wang
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 5%
- RNA modifications and cancer
- Circular RNAs in diseases
- Extracellular vesicles in disease
- Epigenetics and DNA Methylation
Papers in
-
- Epigenetics and DNA Methylation 9
- Circular RNAs in diseases 8
- RNA modifications and cancer 8
-
- MicroRNA in disease regulation 13
- Cancer-related molecular mechanisms research 10
- Co-authors
- Shaogang Qu (6 shared papers)Dongmei Mai (3 shared papers)Fushun Wang (1 shared paper)Zhongxia Qi (2 shared papers)Vera Huang (2 shared papers)Long-Cheng Li (2 shared papers)Linbo Wang (4 shared papers)Robert F. Place (2 shared papers)
- Journals
- Oncotarget (7 papers)Biochemical and Biophysical Research Communications (4 papers)Medicine (4 papers)Cell Death and Disease (3 papers)Scientific Reports (2 papers)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Ji Wang
135 papers receiving 3.8k citations
Ji Wang's Hit Papers
Peers
Comparison fields: 5 of 136
- Cancer Research 1.2k
- Molecular Biology 2.2k
- Immunology 485
- Oncology 556
- Pulmonary and Respiratory Medicine 529
Countries citing papers authored by Ji Wang
This map shows the geographic impact of Ji Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ji Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ji Wang more than expected).
Fields of papers citing papers by Ji Wang
This network shows the impact of papers produced by Ji Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ji Wang. The network helps show where Ji Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ji Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 142 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer Hit paper breakdown → | 2021 | 270 |
| 2 | 2014 | 238 | |
| 3 | 2011 | 236 | |
| 4 | 2017 | 196 | |
| 5 | 2016 | 183 | |
| 6 | 2016 | 177 | |
| 7 | 2020 | 154 | |
| 8 | 2012 | 112 | |
| 9 | 2013 | 103 | |
| 10 | 2018 | 82 | |
| 11 | 2017 | 74 | |
| 12 | 2016 | 73 | |
| 13 | Up-regulation of Tim-3 is associated with poor prognosis of patients with colon cancer. | 2015 | 72 |
| 14 | 2018 | 68 | |
| 15 | 2012 | 67 | |
| 16 | 2019 | 61 | |
| 17 | 2016 | 56 | |
| 18 | 2010 | 56 | |
| 19 | 2014 | 56 | |
| 20 | 2019 | 53 |
About Ji Wang
Ji Wang is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Surgery, having authored 142 papers that have together received 3.9k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (13 papers), Cancer-related molecular mechanisms research (10 papers), Epigenetics and DNA Methylation (9 papers), Circular RNAs in diseases (8 papers), RNA modifications and cancer (8 papers), interferon and immune responses (8 papers), Neuroscience and Neuropharmacology Research (7 papers) and Gastric Cancer Management and Outcomes (6 papers). The work is most often cited by research in Cancer Research (1.2k citations), Molecular Biology (2.2k citations), Immunology (485 citations), Oncology (556 citations) and Pulmonary and Respiratory Medicine (529 citations). Ji Wang has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Shaogang Qu, Dongmei Mai, Fushun Wang, Zhongxia Qi, Vera Huang, Long-Cheng Li, Linbo Wang, Robert F. Place, Jingwei Yu and Jichun Zhou. Their work appears in journals such as Oncotarget, Biochemical and Biophysical Research Communications, Medicine, Cell Death and Disease and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.